Report #2872373

Overview

Sex

Unknown

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (3)

Symptom narrative

Runny nose; could not breath; Nose Blockage; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of runny nose in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced runny nose (Verbatim: Runny nose), difficulty breathing (Verbatim: could not breath) and nasal congestion (Verbatim: Nose Blockage). The outcome of the runny nose, difficulty breathing and nasal congestion were not reported. It was unknown if the reporter considered the runny nose, difficulty breathing and nasal congestion to be related to Arexvy. It was unknown if the company considered the runny nose, difficulty breathing and nasal congestion to be related to Arexvy. Additional Information: GSK receipt date: 27-OCT-2025 The reporter was the patient. The patient had runny nose for quite a while and had nose blocked. The patient could not breath through nose. The batch number was not provided, and we are unable to contact the reporter.